Literature DB >> 12082494

Oxidative stress in malignant and non-malignant phase hypertension.

G Y H Lip1, E Edmunds, S L Nuttall, M J Landray, A D Blann, D G Beevers.   

Abstract

Malignant hypertension (MHT) is a rare and severe form of hypertension characterised by arteriolar necrosis and severe vascular damage, leading to stroke, myocardial infarction and death. We hypothesised that in addition to endothelial damage, MHT may be associated with increased oxidative stress. Lipid hydroperoxides (LHP, an index of oxidative damage) and plasma von Willebrand factor (vWf, an index of endothelial damage/dysfunction) were measured in 16 patients with MHT and compared with 16 non-malignant essential hypertensives and 32 normotensive controls. vWf was greater in MHT (mean 117 iU/dL) than in non-malignant hypertensives (97 iU/dL) or normotensive controls (100 iU/dL) (ANOVA P = 0.017). However, although LHP were greater in MHT (mean 10.6 micromol/L) than in normotensives (4.5 micromol/L, P < 0.001), the levels in MHT were similar to those in non-malignant hypertension (12.3 micromol/L). In conclusion endothelial damage (raised vWf) was more evident in MHT compared with both normotensive controls and with non-malignant hypertension, whilst oxidative stress (raised LHP) was increased to a similar extent in both hypertension groups when compared with normotensive controls. These observations raise the possibility abnormal oxidative stress is probably not the mechanism responsible for the endothelial damage seen in malignant phase hypertension.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082494     DOI: 10.1038/sj.jhh.1001386

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  21 in total

1.  Sex differences in the blood antioxidant defense system in juvenile rats with various genetic predispositions to hypertension.

Authors:  Martina Horvathova; Ingrid Zitnanova; Zuzana Kralovicova; Peter Balis; Angelika Puzserova; Jana Muchova; Michal Kluknavsky; Zdenka Durackova; Iveta Bernatova
Journal:  Hypertens Res       Date:  2015-10-29       Impact factor: 3.872

Review 2.  Potential approaches to reverse or repair renal fibrosis.

Authors:  Desiree Tampe; Michael Zeisberg
Journal:  Nat Rev Nephrol       Date:  2014-02-11       Impact factor: 28.314

Review 3.  Endothelial dysfunction: its role in hypertensive coronary disease.

Authors:  Islam Bolad; Patrice Delafontaine
Journal:  Curr Opin Cardiol       Date:  2005-07       Impact factor: 2.161

Review 4.  Management of hypertension emergencies.

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

5.  Hypertensive crisis in children and adolescents.

Authors:  Tomáš Seeman; Gilad Hamdani; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

Review 6.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

Review 7.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

Review 8.  Oxidative stress as a mediator of cardiovascular disease.

Authors:  Maqsood M Elahi; Yu Xiang Kong; Bashir M Matata
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

Review 9.  Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders.

Authors:  A Zeoli; P Dentelli; M F Brizzi
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

10.  Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension.

Authors:  Anees Ahmad Banday; Mustafa F Lokhandwala
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.